At Signum Surgical, we are advancing a new standard in colorectal care through innovative, minimally invasive solutions—starting with a transformational treatment for anal fistula. Our mission is to empower clinicians and improve patient outcomes by restoring health, dignity, and quality of life around the world.
We are dedicated to developing revolutionary medical devices that set new standards in design, reliability, and clinical effectiveness. Our products aren’t just iterations — they redefine possibilities, delivering meaningful solutions that clinicians trust and patients depend on
By delivering innovative tools, we help physicians improve clinical outcomes and transform patient care. Together with our physician partners, we’re working to bring this life-changing therapy to patients who urgently need new options—and who deserve the chance for a healthier future.
Our high-performing solutions help reduce reinterventions, streamline workflows, and deliver sustained results — driving both clinical and economic value.
We believe every patient deserves the chance to heal and access to effective, life-changing treatment options. By driving innovation in this often-overlooked area of care, we aim to improve outcomes and help people take back control of their health and wellbeing.
We collaborate across roles and functions with trust, respect, and shared purpose — ensuring every perspective is valued and every contribution drives us forward. Through teamwork, open communication, and mutual accountability, we stay aligned on what matters most: delivering measurable, high-impact results that advance our mission and create meaningful value.
Ms. Burns brings over 25 years of Medtech leadership experience from ideation phase through commercialization. Her recent roles include co-founder and CEO to both Cagent Vascular and Intact Vascular (sold to Philips). She has held Sr. Management roles at Embrella Cardiovascular (sold to Edwards Lifesciences), Animas (sold to J&J), Ventrica (sold to Medtronic) and Guidant Corporation.
Medical device entrepreneur with over 12 years of experience in medical device development. Moshe released the world’s first open source surgical device, which has been covered by Wired magazine and recognised by Discover Magazine as one of the top innovations of 2013.
Over 25 years of experience in the research and development of novel medical devices. Eoin has contributed to the development of seven medical devices currently on the market and is a named inventor on 56 granted patent filings. Eoin was awarded ‘Chartered Engineer of the Year 2012’ by Engineers Ireland.
Dennis M. McGrath’s vast executive management experience in private and public companies. Currently he serves as the President and CFO of PAVmed, Inc. (Nasdaq: PAVM), a diversified commercial-stage medical technology company and as the Chief Financial Officer of Lucid Diagnostics, Inc.
Over 30 years of experience as an academic colorectal surgeon. Tony has participated in the research and development of a number of novel medical device and medical pharmaceutical products during his career.
With over 30 years of experience in medical device sales, Carey Redd is exceptionally qualified to serve as Vice President of Sales and lead the commercial launch of the BioHealx device. He brings extensive expertise in introducing innovative solution
Medical device entrepreneur with over 12 years of experience in medical device development. Moshe released the world’s first open source surgical device, which has been covered by Wired magazine and recognised by Discover Magazine as one of the top innovations of 2013.
Over 25 years of experience in the research and development of novel medical devices. Eoin has contributed to the development of seven medical devices currently on the market and is a named inventor on 56 granted patent filings. Eoin was awarded ‘Chartered Engineer of the Year 2012’ by Engineers Ireland.
Jeff is an intellectual property specialist with more than 25 years of experience in early stage medtech companies. Jeff previously served as a Managing Partner at successful incubator The Foundry and holds a JD from the University of Washington and a BS in Mechanical Engineering from Stanford.
Dr Collins is a leading expert in the medical technology sector and serves on the Board of Directors of several US and Irish life-science companies. A former Vice President of International Operations for Boston Scientific, where he served for 10 years, Dr Collins has held a number of senior executive positions.
Alan brings more than 40 years of experience in the medical device industry. Alan is involved with multiple life science companies as a CEO and as a board member and was a Senior Advisor to Frazier Healthcare Partners. Alan is an expert in bioabsorbable materials and the inventor of Vicryl
Please get in touch using the form or reach out directly via the contact details provided.
"*" indicates required fields
